It has been proved that RNAi-induced heparanase silencing can inhibit cell invasion of gastric carcinoma[19], hepatocellular carcinoma[20] and embryonal rhabdomyosarcoma[21]. Here, HPSE is linked to hepatocellular carcinoma.